[{"NetIncomeLoss_1_Q1_USD":-78335000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"DepreciationAndAmortization_1_Q1_USD":2222000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":17738000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":91456000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"RestrictedCashCurrent_0_Q1_USD":194000.0,"InterestPaidNet_1_Q1_USD":10000.0,"PaymentsToAcquireShortTermInvestments_1_Q1_USD":94055000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-135000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":161000.0,"AssetsCurrent_0_Q1_USD":464307000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":14096130.0,"IncomeTaxesPaidNet_1_Q1_USD":8000.0,"CommonStockSharesIssued_0_Q1_shares":84075000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":433837000.0,"Assets_0_Q1_USD":529637000.0,"ShareBasedCompensation_1_Q1_USD":12268000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":11930000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":13499000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q1_shares":20972916.0,"Liabilities_0_Q1_USD":130600000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":12569000.0,"ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_1_Q1_USD":109751000.0,"FinanceLeasePrincipalPayments_1_Q1_USD":66000.0,"ProceedsFromStockPlans_1_Q1_USD":1749000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-90000.0,"AccountsReceivableNetCurrent_0_Q1_USD":9610000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_1_Q1_USD":-360000.0,"IncreaseDecreaseInDeferredRevenue_1_Q1_USD":6058000.0,"CommonStockValue_0_Q1_USD":8000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1601784000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q1_USD":64032000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q1_USD":369665000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":2892000.0,"RestrictedCash_0_Q1_USD":1400000.0,"RestrictedStockValueSharesIssuedNetOfTaxWithholdings_1_Q1_USD":1231000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-78470000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":9555000.0,"OtherAssetsNoncurrent_0_Q1_USD":729000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":151097000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_1_Q1_USD":-7672000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":2457000.0,"IncreaseDecreaseInOtherCurrentLiabilities_1_Q1_USD":1510000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":8360000.0,"CommonStockSharesOutstanding_0_Q1_shares":84075000.0,"RestrictedCashNoncurrent_0_Q1_USD":1200000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":21838000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":1231000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":12268000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-65698000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q1_USD":369805000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1202916000.0,"LiabilitiesCurrent_0_Q1_USD":84194000.0,"AccountsPayableCurrent_0_Q1_USD":17355000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":152491000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":19342000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":-38000.0,"InterestReceivable_0_Q1_USD":700000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":1245000.0,"ProceedsFromPaymentsForOtherFinancingActivities_1_Q1_USD":-17000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":51471000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":-49307000.0,"AccretionExpense_1_Q1_USD":21000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":2197000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":31811000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0_Q1_USD":64011000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-1828000.0,"CommonStockSharesAuthorized_0_Q1_shares":500000000.0,"OperatingIncomeLoss_1_Q1_USD":-78245000.0,"AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_0_Q1_USD":433676000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":35497000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":529637000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":12786000.0,"PreferredStockSharesAuthorized_0_Q1_shares":20000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":12268000.0,"CapitalUnitsAuthorized_0_Q1_shares":520000000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":73309000.0,"OperatingExpenses_1_Q1_USD":81797000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.86,"ProfitLoss_1_Q1_USD":-78335000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":2026000.0,"OtherLiabilitiesCurrent_0_Q1_USD":7901000.0,"StockholdersEquity_0_Q1_USD":399037000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":64059000.0,"ShortTermInvestments_0_Q1_USD":284064000.0,"Ticker":"ATRA","CIK":"1604464","name":"ATARA BIOTHERAPEUTICS, INC.","OfficialName":"Atara Biotherapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"734540687.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210504"}]